Abbott Receives FDA Approval for IOS-Compatible App Allowing People Living with Chronic Pain and Movement Disorders to Personalize Therapy via Their Mobile Device

Originally published on Abbott.com

– Apple‡ smartphone-compatible digital health tool fits within the company’s broader NeuroSphere™ Digital Care connected care management platform, which is designed to optimize care for chronic pain and movement disorders

– NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered

– Approval of the Patient Controller app is the latest launch under the NeuroSphere Digital Care(1) platform 

Abbott (NYSE: ABT) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple‡ smartphone devices. At Abbott, this approval allows patients living with neurological conditions, including chronic pain or movement disorders, the ability to manage therapy directly from their personal smartphone.2

With this app approval, the need to carry a separate patient programmer device is eliminated, streamlining the patient’s experience and seamlessly integrating therapy management into their life. This is an important step in the integration and connection of digital health tools that ultimately help patients live fuller, healthier lives.

“For physicians who are prescribing and implanting neuromodulation technologies, the ability to integrate therapies into one’s everyday life is key,” said Alexander Escobar, M.D., Clinical Assistant Professor of Anesthesiology and Pain Medicine at The University of Toledo, OH. “The COVID-19 global health crisis has demanded access to virtual treatment options, especially for those individuals with chronic medical conditions that may have difficulty coming to see their physician or would prefer not to leave their own home. To ensure our patients are receiving the care they need in the appropriate setting, close follow up is critical. Physicians have the ability to remain engaged with their patients through the Apple device, allowing them to interact and treat debilitating chronic pain.”

“The ability to support the changing needs of individuals living with debilitating chronic conditions, like Parkinson’s, without them having to leave their homes is vitally important in today’s world,” said Drew Falconer, M.D., Director of the Parkinson’s and Movement Disorders Center, Inova Health System in Virginia. “Abbott’s NeuroSphere Digital Care solution, including the new Patient Controller app, allows patients to handle one single device and using the FaceTime application, interact with their provider teams in a convenient, easy-to-use interface — an important attribute for those with tremors or have challenges with mobility.”

The Patient Controller app will be integrated into Abbott’s broader NeuroSphere Digital Care connected care management platform, which became available in May. It is compatible with Abbott’s suite of neuromodulation technologies, including Infinity™ DBS System for patients with Parkinson’s disease or essential tremor, Proclaim™ XR SCS System for patients living with chronic pain, and Proclaim™ DRG Neurostimulation System for patients with chronic pain in the lower limbs caused by complex regional pain syndrome or causalgia. This integration across all Abbott neuromodulation technologies allows physicians to more easily treat the individual needs of each patient within their practice who have an Abbott device and Apple smartphone.

“Patients are seeking digital options to better engage with their healthcare providers and manage their chronic conditions remotely – and this has never been more evident than in today’s pandemic where virtual care is necessary,” said Keith Boettiger, vice president, Neuromodulation, Abbott. “With the continuing rise in interest and demand for these technologies, Abbott, as a pioneer in patient-centric neuromodulation technology, is advancing the field of digital health to deliver on the promise of digital care. The approval of Abbott’s Patient Controller app with personalized access to therapy is a landmark event, as we are now able to provide patients a way to access personalized therapy from a compatible and secure iOS device so that people can live their lives and seamlessly manage conditions like chronic pain and movement disorders.”

The Patient Controller app with personalized access to therapy will be made available starting in the coming weeks. For important safety information please visit the websites for Infinity DBSProclaim XR and Proclaim DRG devices.

Latest News

The Importance of Business-Community Partnerships

Businesses increasingly play a key role in building stronger communities. It’s something that people in the past few years have come to expect. It’s created not only a way to improve local communities, but also boost an organization’s employee morale, loyalty and brand reputation. One of the main ways businesses…

CDO Series: Humana’s Carolyn Tandy

Following the murder of George Floyd, the role of Chief Diversity Officers has become more important as companies started to be more intentional with their diversity, equity and inclusion efforts, which has made the last few years tumultuous for many CDOs. In the first interview of a series of articles…

The Importance of Education-Focused Community Partnerships

Community partnerships focused on education are vital to creating and improving the network that connects diverse, underrepresented students and young professionals with employers seeking new talent. For Stephanie Turner, VP of Inclusion, Diversity and Social Innovation at MITRE, advocation starts at the root of education: grade school curriculum, especially in…

5 Biggest News Stories of the Week: August 4

As the saying goes, the news never stops — but there’s a lot of it out there, and all of it doesn’t always pertain to our readers. In this weekly news roundup, we’ll cover the top news stories that matter most to our diversity focused audience. 1. The Supreme Court’s…

Mastercard Names Ellen Jackowski Chief Sustainability Officer

Originally published at mastercard.com. Mastercard ranked No. 2 on The DiversityInc Top 50 Companies for Diversity list in 2022.   Mastercard announced Ellen Jackowski will join the company as Chief Sustainability Officer starting July 25, 2022. In this role, she will be instrumental in further integrating Mastercard’s Environmental, Social and Governance…